FDA Investigator Andrew E Kay
Andrew E Kay has conducted inspections on 83 sites in 2 countries as of 08 Jun 2021. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
83
Last Inspection Date:
08 Jun 2021
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Andrew E Kay:
Adam S Freeman,
Alex G Kalugin,
Alexandra M Cossi,
Alexis R Ajello,
Alice A Blair,
Alla Dubrovsky,
Andrew B Slarve,
Andrew T Todd,
Andrew Tadros,
Angel K Sandhu,
Angela D Wise,
Anna J Vickrey,
Anna L Viveros Hernandez,
Ashar P Parikh,
Belinda E Clifton,
Benny Y Gong,
Bradley J Maunder,
Breena L D'ambrogi,
Brian P Hendrickson,
Brian R Henderson,
Bruce D Broidy,
Capri R Woolridge,
Carol A Elems,
Celeste K Wong,
Chloe Anne Leong,
Christine M Parmentier,
Christopher J Lee,
Cindy W Lewis,
Courtney R Bolton,
Courtney R Warren,
Cynthia L Ford,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Daniel Velasquez,
Darla R Bracy,
David A Lum,
David G Eng,
David J Leray,
Deborah K Richardson,
Dena L Jacobs,
Denise Connelly,
Douglas J Snyder,
Dustin P Tran,
Edna J Hidalgo,
Elizabeth P Mayer,
Elodie X Tong Lin,
Elva M Ibarra,
Emal Wahab,
Emil P Wang, JD,
Emmanuel O Kerry,
Eric J Heinze,
Erica Fernandez,
Erica L Nicoll,
Erica R Pomeroy,
Estefania Fernandez,
Gillenwater,
Gina M Hall,
Glen E Harelson,
Gulshan R Anand,
Helen J Hamaoka,
Henry K Lau,
Huy T Pham,
Ian J Thomson,
Ingrid A Zambrana,
Ismael Garibay,
Jacqueline O Snell,
James A Lane,
James C Lee, PharmD,
James C Yee,
Janice R Small,
Janice Wai,
Jazmine M Welcher,
Jeanmaire Hryshko,
Jeanne A Young,
Jeffrey W Shrifter, DPM,
Jennifer Crumb,
Jennifer L Johnson,
Jennifer S King,
Jenny K Yee,
Jessica B Darneille,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Gonzalez,
John A Liu,
Jolene S Hedgecock,
Jonathon A Yenovkian,
Joseph A Seitz, III,
Joseph M Willems,
Joseph Tibay,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karen L Robles,
Karen M Willis,
Karla J Gibler,
Kawshalya Pathiraja,
Kay M Vialpando,
Keren Arkin,
Kevin Lee,
Kibily D Dembele,
Kimberly L Anderson,
Kristin M Abaonza,
Krystina M Jackson,
Larkin R Buckalew,
Lea Lakes,
Ligia M Cline,
Ligia M Sanders,
Lija V Fellows,
Lillian C Lopez,
Lilly O Barton,
Linda Linh N Adams,
Linda S Shook,
Lisa H Nakagawa,
Lopez,
Lorenzo F Edwards,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lucila B Nwatu,
Luis A Solorzano,
Lydia S Chan,
Lynda L Perry, PhD,
Mabel M Lee,
Macropolk,
Maridali Deleon Torres,
Marissa J Chan,
Marjorie D Santos,
Mark E Baldwin,
Mark L Collins,
Matthew A Walburger,
Mcgrewp,
Megan E Kulas,
Michelle L Lopez,
Michelle L Orner,
Michelle L Tripp,
Min Shanmabel Liu,
Monique C Lo,
Ngoc B Kelsch,
Nianna C Burns,
Nicole Yuen,
Nympha V Florendo,
Peter E Baker,
Phung,
Quynh H Strandberg,
Randall J Plunkett,
Randall P Zielinski,
Randy L Elsberry,
Rebecca E Sulpacio,
Roberta K Smith,
Roberto Macina,
Robles,
Ronald P Boyce,
Roy C Stephens,
Rumany C Penn, PharmD,
Sabino S Camacho,
Sandra S Saniga,
Scott J Matsuda,
Sean P Desbrow,
Seema S Singh,
Sergio Chavez (NMI),
Seth A Abbott,
Sharon L Shane,
Sondra R Davis,
Stephen G Mclane,
Steve P Yost,
Steven B Chiu,
Steven C Himebaugh,
Steven J Branch,
Steven M Galvez,
Stuart W Russell,
Terrence Gee,
Thomas N Adjabeng,
Thomas W Gordon,
Tiffany Chao,
Timothy C Grome,
Tomanik'e C Banks,
Travelle D Mason,
Tristian E Strait,
Vebina K Sethi,
Victoria L Morgan,
Victoria Taylor,
Wayne L Jefferson,
Wen Jun Peng,
Willemsj,
William J Foust,
William J Weis,
William V Millar
Andrew E Kay's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2017 | FDA 483 | H.A. Rider & Sons - Form 483, 2017-04-12 |
October, 2016 | FDA 483 | Olam Tomato Processors, Inc. - Form 483, 2016-10-27 |
May, 2016 | FDA 483 | Dairy Farmers of America, Inc. - Form 483, 2016-05-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more